How to design and launch a successful Clinical Trial Manufacturing.

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

The main problem is that most vector production technologies were developed for the lab, rather than to support industrial ...

Previous efforts to circumvent the problem of the size limitation imposed by the AAV vector have focused mainly on altering the candidate genes into ‘mini-expression cassettes’ suitable for ...

On this episode of GEN Live, we’ll talk to experts in delivery with a focus on AAV vectors. We’ll discuss the successes the field has experienced, the challenges that remain, new technologies that may ...

Christopher J. Walkey, assistant professor in integrative physiology at Baylor. "To assist researchers in the selection of the optimal AAV vector for their application, we have generated a detailed ...

Concomitantly, the regulatory environment has expanded in parallel to the use of AAV. The ongoing revision of the ICH Q5A guidance—relative to the viral safety of biotechnology products derived from ...

"To assist researchers in the selection of the optimal AAV vector for their application, we have generated a detailed map of viral delivery to tissues in mice, the most commonly used experimental ...

To ensure they have the materials required for each testing phase, researchers can also rely on off-the-shelf plasmid and viral vector solutions, such as those offered by Charles River as a part of ...